Company intelligence / Profile preview

Versant Ventures

San Francisco, California, United Statesversantventures.com ↗

Ownership: Private
Employees: ~55
Development stage: Other

Overview

Versant Ventures does not develop drugs itself but has enabled over 100 successful IPOs or acquisitions of its portfolio companies since 1999. Its investments span early-stage discovery through late clinical development across biotech sectors globally.

Therapeutic areas: CardiovascularMetabolic DisordersImmunologyEndocrinologyOncologyNeurology
Modalities: Small moleculeGene therapyMonoclonal antibodymRNA-based drugsCell therapy
Industry: Investors

Partnerships

Extensive academic partnerships (>30 institutions globally)Co-investments with major VCs/pharma including Bayer and Vertex via portfolio companies like CRISPR Therapeutics

Beyond the preview

Go deeper on Versant Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Versant Ventures.

Explore the full profile